Genmab 2016 Annual Report (Genmab A/S)
(WorldNews Denmark)

(Source: Genmab A/S) Company Announcement Copenhagen, Denmark; February 22, 2017 -Genmab A/S (Nasdaq Copenhagen: GEN) announced today its Annual Report for 2016. Below is a description of business progress and financial performance for the year, and financial outlook for 2017 from the report. The full report is attached as a PDF file and can be found on the investor section of the company`s website, www.genmab.com. 2016 ACHIEVEMENTS Business Progress Maximize daratumumab progress Launch DARZALEX in US and other approved territories - Achieved CHMP decision on monotherapy application - Achieved Phase III multiple myeloma (MM) interim efficacy analysis in relapsed / refractory MM settings [POLLUX...